These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4474792)

  • 1. Coagulation studies in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
    Ekberg M; Nilsson IM; Denneberg T
    Acta Med Scand; 1974 Nov; 196(5):373-82. PubMed ID: 4474792
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Monteagudo J; Pereira A; Reverter JC; Pijoan J; Tusell J; Puig L; Ordinas A; Castillo R
    Thromb Haemost; 1991 Nov; 66(5):515-9. PubMed ID: 1803613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
    Brain MC; Neame PB
    Semin Thromb Hemost; 1982 Jul; 8(3):186-97. PubMed ID: 6753155
    [No Abstract]   [Full Text] [Related]  

  • 5. [Congenital factor XIII deficiency: studies in an infant and his family].
    Mertner MF
    Monatsschr Kinderheilkd (1902); 1972 Jan; 120(1):28-31. PubMed ID: 5016722
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intravascular coagulation and degradation products of fibrinogen and fibrin. (Review of new findings and diagnostic possibilities].
    Hrubisková K
    Bratisl Lek Listy; 1974; 62(1):111-9. PubMed ID: 4603642
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of intravascular coagulation in the hemolytic-uremic syndrome.
    Kisker CT; Rush RA
    Am J Dis Child; 1975 Feb; 129(2):223-6. PubMed ID: 1119457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation studies in haemolytic uraemic syndrome.
    Willoughby ML; Murphy AV; McMorris S; Jewell FG
    Arch Dis Child; 1972 Oct; 47(255):766-71. PubMed ID: 5086510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kasabach-Merritt syndrome: coagulo--analytical observations.
    Rodriguez-Erdmann F; Button L; Murray JE; Moloney WC
    Am J Med Sci; 1971 Jan; 261(1):9-15. PubMed ID: 5165168
    [No Abstract]   [Full Text] [Related]  

  • 10. Coagulation defect associated with presumed amniotic fluid embolism in the mid-trimester of pregnancy.
    Woodfield DG; Galloway RK; Smart GE
    J Obstet Gynaecol Br Commonw; 1971 May; 78(5):423-9. PubMed ID: 5558328
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute hepatic necrosis of hepatitis and mushroom poisoning. The value of coagulation tests in their differentiation, prognostic assessment and pathogenesis.
    Herold R; Straub PW
    Helv Med Acta; 1973; 37(1):5-24. PubMed ID: 4720492
    [No Abstract]   [Full Text] [Related]  

  • 12. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome following allogeneic bone marrow transplantation.
    Takatsuka H; Wakae T; Mori A; Okada M; Suehiro A; Okamoto T; Kakishita E
    Bone Marrow Transplant; 2002 Jun; 29(11):907-11. PubMed ID: 12080356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Douglas AS: The behaviour of the coagulation and fibrinolytic mechanisms in abruptio placentae.
    Bonnar J; McNicol GP
    J Obstet Gynaecol Br Commonw; 1969 Sep; 76(9):799-805. PubMed ID: 5823679
    [No Abstract]   [Full Text] [Related]  

  • 15. Excess intravascular coagulation--diagnosis and clinical significance.
    Stuart J
    Proc R Soc Med; 1974 Mar; 67(3):204. PubMed ID: 4820818
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombotic thrombocytopenic purpura. Three cases with platelet and fibrinogen survival studies.
    Berberich FR; Cuene SA; Chard RL; Hartmann JR
    J Pediatr; 1974 Apr; 84(4):503-9. PubMed ID: 4858082
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of the determination of prostacyclin metabolism in the management of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
    Túri S; Beattie JT
    Orv Hetil; 1986 Jul; 127(29):1747-51. PubMed ID: 3526247
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in blood coagulation and fibrinolysis during the postoperative period.
    Ygge J
    Am J Surg; 1970 Mar; 119(3):225-32. PubMed ID: 5443923
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasmatic parameters of coagulation activation in thrombotic microangiopathy.
    Sagripanti A; Carpi A; Baicchi U; Morganti M; Rosaia B; Nicolini A; Mittermayer C
    Biomed Pharmacother; 1996; 50(8):357-62. PubMed ID: 8952855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet aggregating factor in the epidemic form of hemolytic-uremic syndrome in childhood.
    Monnens L; van de Meer W; Langenhuysen C; van Munster P; van Oostrom C
    Clin Nephrol; 1985 Sep; 24(3):135-7. PubMed ID: 4042442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.